Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Seattle Genetics
Special Reports
The top 15 biopharma licensing deals of 2020
Oncology, specifically immuno-oncology, was the dominant theme in biopharma licensing last year, as cancer drugs accounted for half of the top deals.
Phil Taylor
Apr 27, 2021 3:00am
Seattle Genetics' ADC curbs hard-to-treat cervical cancer
Sep 21, 2020 10:20am
Seattle gets second prize in a mini ADC weekend frenzy
Sep 14, 2020 6:45am
The top 10 highest paid biopharma R&D executives in 2019
Jul 20, 2020 3:00am
Genmab, Seattle Genetics eye FDA filing after seeing cancer data
Jun 30, 2020 7:20am
How a Seattle Genetics cancer drug could help lupus patients
Apr 9, 2020 8:35am
